Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,700.00
Ask: 1,779.00
Change: 0.00 (0.00%)
Spread: 79.00 (4.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Investec And Jefferies Keep Buy On Lloyds

Thu, 28th Apr 2016 08:28

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
Investec Reiterates Buy And 78p Price Target On Lloyds
----------
Jefferies Maintains Buy And "Street High" 108p Price Target On Lloyds
----------
Deutsche Bank Ups Barclays Target To 180p From 178p, Keeps Hold
----------
HSBC RAISES STANDARD CHARTERED PRICE TARGET TO 550 (450) PENCE - 'HOLD'
----------
EXANE BNP RAISES STANDARD CHARTERED TARGET TO 450 (385) PENCE - 'UNDERPERFORM'
----------
Deutsche Bank Ups Antofagasta Target To 470p From 450p, Keeps Hold
----------
BERENBERG CUTS ANTOFAGASTA PRICE TARGET TO 365 (375) PENCE - 'SELL'
----------
HSBC RAISES GLAXOSMITHKLINE PRICE TARGET TO 1865 (1800) PENCE - 'BUY'
----------
SOCGEN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1300 (1250) PENCE - 'SELL'
----------
Jefferies Initiates United Utilities Group With Hold, Target At 890p
----------
GOLDMAN CUTS MARKS & SPENCER PRICE TARGET TO 380 (455) PENCE - 'SELL'
----------
GOLDMAN RAISES INTU PROPERTIES TO 'NEUTRAL' ('SELL') - TARGET 350 (335) PENCE
----------
GOLDMAN CUTS NEXT TO 'SELL' ('NEUTRAL') - TARGET 5000 (6400) PENCE
----------
RBC CAPITAL RAISES BAT PRICE TARGET TO 3400 (3300) PENCE - 'UNDERPERFORM'
----------
MORGAN STANLEY RAISES BAT PRICE TARGET TO 4300 (4100) PENCE - 'EQUAL-WEIGHT'
----------
RBC CAPITAL RAISES RECKITT PRICE TARGET TO 7100 (6600) PENCE - 'SECTOR PERFORM'
----------
RBC CAPITAL RAISES UNILEVER PLC PRICE TARGET TO 3300 (3200) PENCE - 'OUTPERFORM'
----------
MORGAN STANLEY INITIATES BUNZL WITH 'EQUAL-WEIGHT' - TARGET 2200 PENCE
----------
FTSE 250
----------
DEUTSCHE BANK CUTS STAGECOACH PRICE TARGET TO 365 (390) PENCE - 'BUY'
----------
RBC CUTS STAGECOACH TARGET TO 280 (315) PENCE - 'SECTOR PERFORM'
----------
DEUTSCHE BANK RAISES COBHAM TO 'HOLD' ('SELL') - CUTS TARGET TO 185 PENCE
----------
JPMORGAN RAISES EVRAZ PRICE TARGET TO 98 (79) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES CAIRN ENERGY PRICE TARGET TO 230 (220) PENCE - 'EQUAL WEIGHT'
----------
SOCGEN RAISES HENDERSON GROUP PRICE TARGET TO 260 (235) PENCE - 'HOLD'
----------
CITIGROUP RAISES HENDERSON GROUP PRICE TARGET TO 289 PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
JPMORGAN RAISES FENNER PRICE TARGET TO 111 (110) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES CAMBIAN GROUP PRICE TARGET TO 119 (109) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES PREMIER OIL PRICE TARGET TO 75 (50) PENCE - 'EQUAL WEIGHT'
----------
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.